Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Matinas BioPharma Holdings, Inc.
  6. Consensus
    MTNB   US5768101058

MATINAS BIOPHARMA HOLDINGS, INC.

(MTNB)
  Report
Delayed Nyse  -  05/19 04:00:00 pm EDT
0.6651 USD   +2.24%
05/12TRANSCRIPT : Matinas BioPharma Holdings, Inc., Q1 2022 Earnings Call, May 12, 2022
CI
05/12MATINAS BIOPHARMA HOLDINGS, INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
05/12Matinas BioPharma Reports First Quarter 2022 Financial Results and Operational Highlights
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on MATINAS BIOPHARMA HOLDINGS, INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) MATINAS BIOPHARMA HOLDINGS, INC.
Analyst Recommendations on MATINAS BIOPHARMA HOLDINGS, INC.
2021MATINAS BIOPHARMA : Piper Sandler Cuts Matinas BioPharma Holdings to Neutral From Overweight, Price Target to ..
MT
2021MATINAS BIOPHARMA : HC Wainwright Adjusts Price Target on Matinas BioPharma Holdings to $3 From $4, Maintains ..
MT
More recommendations
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 0,65 $
Average target price 2,75 $
Spread / Average Target 323%
High Price Target 3,00 $
Spread / Highest target 361%
Low Price Target 2,00 $
Spread / Lowest Target 207%
Consensus detail
Consensus revision (last 18 months)